Cefdinir Powder, For Suspension
Product Images NDC 68071-5318

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68071-5318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5318 1)

Pdp (68071 5318 1)
Label for Cefdinir 125 mg/5 mL oral suspension powder from NuCare Pharmaceuticals, Inc. The 100 mL bottle contains powder for reconstitution, making 5 mL of suspension with 125 mg Cefdinir per dose. Instructions to reconstitute with 63 mL water and warnings about temperature storage and child safety are included. The label features lot, expiration, and serial number placeholders, plus a QR code and barcodes.*
FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical Structure (Cefdinir Str)
Chemical structure diagram of the active ingredient cefdinir, showing its molecular formula with nitrogen, sulfur, oxygen, carbon, and hydrogen atoms connected by various bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.